Clinical trial
Investigation of Novel Biomarkers and Definition of the Role of the Microbiome In Graves' Orbitopathy
NCT02373995 is registered in ClinicalTrials.gov with Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Investigation of Novel Biomarkers and Definition of the Role of the Microbiome In Graves' Orbitopathy
- Lead sponsor
- Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
- Phase
- Phase 1/2
- Overall status
- Unknown status
- Start date
- February 28, 2015
- Completion date
- December 31, 2016
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
graves' disease